Skip to content

Effect of Breathing Exercise on Intradialytic Hypotension in Hemodialysis Patients

The Effect of Breathing Exercise on Intradialytic Hypotension and the Evaluation of Risk Factors in Hemodialysis Patients: A Randomized Controlled Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07773311
Enrollment
66
Registered
2026-08-19
Start date
2025-10-06
Completion date
2026-03-03
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis, Intradialytic Hypotension

Keywords

Breathing Exercise, Hemodynamic Stability, Blood Pressure, Intradialytic Hypotension, Hemodialysis Patients

Brief summary

Intradialytic hypotension is a common complication of hemodialysis that may adversely affect patient safety and treatment tolerance. This randomized controlled study aimed to evaluate the effect of a breathing exercise on the development of intradialytic hypotension (IDH) and hemodynamic stability in patients receiving hemodialysis and to determine the factors associated with the development of IDH. A total of 66 eligible patients were enrolled in the study and randomly assigned to the intervention and control groups. Six participants discontinued the study because of death, unwillingness to perform the breathing exercise, or unwillingness to continue participation. The study was completed with 60 patients. Patients in the intervention group performed the breathing exercise during hemodialysis sessions for four weeks and 12 sessions, while patients in the control group received routine care. Intradialytic hypotension and hemodynamic parameters were monitored throughout the study.

Interventions

BEHAVIORALBreathing Exercise

Participants were taught the breathing exercise face-to-face by the researcher. Each breathing cycle consisted of four consecutive stages: inhalation through the nose for 4 seconds using the diaphragm, holding the breath for 4 seconds, slow exhalation for 4 seconds, and holding the breath after exhalation for 4 seconds. Each cycle lasted 16 seconds. The exercise was performed between the 60th and 90th minutes of the hemodialysis session, after needle insertion and early ultrafiltration procedures had been completed. During each session, participants performed two 10-minute exercise periods separated by a 5-minute rest. The intervention was administered three times per week for four weeks, for a total of 12 sessions. The exercise was discontinued if dizziness, dyspnea, or symptomatic hypotension developed.

Sponsors

Yasemin Çelik
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Eligible participants were randomly assigned to two parallel groups: the intervention group, which performed a breathing exercise during hemodialysis sessions in addition to routine care, and the control group, which received routine care alone. The intervention was implemented for four weeks and 12 hemodialysis sessions.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18 to 65 years * Receiving regular hemodialysis treatment for at least 3 months * Able to read and write in Turkish * Able to understand and answer the research questions * Able to learn and perform the breathing exercise correctly * Willing to participate and providing written informed consent

Exclusion criteria

* Resting peripheral oxygen saturation (SpO2) below 92% * History of unstable angina or serious arrhythmia within the previous 3 months * Moderate to severe chronic obstructive pulmonary disease or restrictive lung disease * Cognitive impairment * History of recurrent severe intradialytic hypotension

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of Intradialytic HypotensionDuring each hemodialysis session over 4 weeks (12 sessions)Intradialytic hypotension was assessed during each hemodialysis session. It was defined as a decrease of at least 20 mmHg in systolic blood pressure or at least 10 mmHg in mean arterial pressure, accompanied by symptoms such as dizziness, nausea, or muscle cramps. The occurrence of intradialytic hypotension was recorded as yes or no for each of the 12 sessions.

Secondary

MeasureTime frameDescription
Change in Systolic Blood PressureDuring each hemodialysis session over 4 weeks (12 sessions)Systolic blood pressure was measured in mmHg before and after the breathing exercise in the intervention group and at corresponding time points in the control group during each hemodialysis session.
Change in Diastolic Blood PressureDuring each hemodialysis session over 4 weeks (12 sessions)Diastolic blood pressure was measured in mmHg before and after the breathing exercise in the intervention group and at corresponding time points in the control group during each hemodialysis session.
Change in Mean Arterial PressureDuring each hemodialysis session over 4 weeks (12 sessions)Mean arterial pressure was calculated in mmHg using the formula: (systolic blood pressure + 2 x diastolic blood pressure) / 3, based on measurements obtained before and after the breathing exercise in the intervention group and at corresponding time points in the control group.
Change in Heart RateDuring each hemodialysis session over 4 weeks (12 sessions)Heart rate was measured in beats per minute before and after the breathing exercise in the intervention group and at corresponding time points in the control group during each hemodialysis session
Change in Peripheral Oxygen SaturationDuring each hemodialysis session over 4 weeks (12 sessions)Peripheral oxygen saturation was measured as a percentage using pulse oximetry before and after the breathing exercise in the intervention group and at corresponding time points in the control group during each hemodialysis session.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORYasemin Celik, PhD

Afyonkarahisar Health Sciences University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026